Astrid Hirschmann

KRAS and BRAF mutations in ovarian tumors: A comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants

Doris Mayr, Astrid Hirschmann, U. Löhrs et al. · Gynecologic Oncology · 2006 · 221 citations

Tumoral Pathology, Tumor Heterogeneity, Medicine +9

MDM-2 Oncoprotein Overexpression, p53 Gene Mutation, and VEGF Up-Regulation in Angiosarcomas

Christian Zietz, Matthias Rössle, Christian Haas et al. · American Journal Of Pathology · 1998 · 180 citations · Full text

Angiogenesis, Mdm-2 Oncoprotein Overexpression, P53 Gene Mutation +6

A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib

Oliver Gautschi, Chantal Pauli, Klaus Strobel et al. · Journal of Thoracic Oncology · 2012 · 147 citations · Full text

Tumor Biology, Medicine, Pathology +6

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

Marileila Varella‐Garcia, Joachim Diebold, David A. Eberhard et al. · Journal of Clinical Pathology · 2009 · 117 citations · Full text

Engineering, Pathology, Situ Hybridisation +20

A Patient with Lung Adenocarcinoma and RET Fusion Treated with Vandetanib

Oliver Gautschi, Thilo Zander, Franziska Aebersold Keller et al. · Journal of Thoracic Oncology · 2013 · 101 citations

Surgical Oncology, Ret Fusion Treated, Medicine +11